Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Increasing incidence of multiple sclerosis among women in Buenos Aires: a 22 year health maintenance organization based study.
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy.
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis.
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients.
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
Bladder function and falls in individuals with multiple sclerosis.
Neuromyelitis optica spectrum disorder coinciding with hematological immune disease: A case report.
Parasites and immunotherapy: with or against?
Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis.
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.
Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Cognitive reserve in multiple sclerosis.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Large amplitude cortical evoked potentials (EPs) in non-epileptic patients. Reviving an old neurophysiologic tool to help detect CNS Pathology.
Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.
Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.
Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome.
Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis.
Glial Cells and Integrity of the Nervous System.
A New Strategy for Fast MRI-Based Quantification of the Myelin Water Fraction: Application to Brain Imaging in Infants.
Pages
« first
‹ previous
…
777
778
779
780
781
782
783
784
785
…
next ›
last »